HeartSciences Statistics
Total Valuation
HeartSciences has a market cap or net worth of $3.87 million. The enterprise value is $4.26 million.
Important Dates
The next estimated earnings date is Monday, July 28, 2025, after market close.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HeartSciences has 1.08 million shares outstanding. The number of shares has increased by 290.34% in one year.
| Current Share Class | 1.08M |
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | +290.34% |
| Shares Change (QoQ) | +7.48% |
| Owned by Insiders (%) | 7.88% |
| Owned by Institutions (%) | 7.72% |
| Float | 995,740 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.07 |
| P/TBV Ratio | 21.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.67.
| Current Ratio | 1.02 |
| Quick Ratio | 0.73 |
| Debt / Equity | 1.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.41 |
Financial Efficiency
Return on equity (ROE) is -163.47% and return on invested capital (ROIC) is -71.82%.
| Return on Equity (ROE) | -163.47% |
| Return on Assets (ROA) | -62.95% |
| Return on Invested Capital (ROIC) | -71.82% |
| Return on Capital Employed (ROCE) | -389.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$567,804 |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.50% in the last 52 weeks. The beta is 2.58, so HeartSciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.58 |
| 52-Week Price Change | -35.50% |
| 50-Day Moving Average | 3.40 |
| 200-Day Moving Average | 3.40 |
| Relative Strength Index (RSI) | 49.06 |
| Average Volume (20 Days) | 47,243 |
Short Selling Information
The latest short interest is 9,536, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 9,536 |
| Short Previous Month | 9,037 |
| Short % of Shares Out | 0.88% |
| Short % of Float | 0.96% |
| Short Ratio (days to cover) | 0.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.31M |
| Pretax Income | -6.61M |
| Net Income | -8.52M |
| EBITDA | -8.27M |
| EBIT | -8.31M |
| Earnings Per Share (EPS) | -$10.22 |
Full Income StatementBalance Sheet
The company has $2.60 million in cash and $2.99 million in debt, giving a net cash position of -$390,557 or -$0.36 per share.
| Cash & Cash Equivalents | 2.60M |
| Total Debt | 2.99M |
| Net Cash | -390,557 |
| Net Cash Per Share | -$0.36 |
| Equity (Book Value) | 1.79M |
| Book Value Per Share | 1.73 |
| Working Capital | 57,632 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.40 million and capital expenditures -$51,956, giving a free cash flow of -$7.45 million.
| Operating Cash Flow | -7.40M |
| Capital Expenditures | -51,956 |
| Free Cash Flow | -7.45M |
| FCF Per Share | -$6.89 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HeartSciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -290.34% |
| Shareholder Yield | -290.34% |
| Earnings Yield | -220.09% |
| FCF Yield | -192.54% |
Analyst Forecast
The average price target for HeartSciences is $13.00, which is 263.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 263.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 17, 2024. It was a reverse split with a ratio of 0.01:1.
| Last Split Date | May 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.01:1 |
Scores
HeartSciences has an Altman Z-Score of -22.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.29 |
| Piotroski F-Score | 1 |